Syneos Health Extends Partnership with Medable
Partnership started in April 2021 will continue to advance clinical trials through DCT solutions.
Syneos Health announced it has extended its strategic partnership with Medable. Syneos Health first partnered with Medable in April 2021. Over the past 18 months, Syneos Health and Medable have collaborated on more than 15 clinical trials with the aim of reaching 21,000 patients across multiple therapeutic areas. Extended work will continue to deliver DCT solutions to address customers’ customized needs.
Read more about the partnership
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
Everything to Know About FDA’s Push Towards Radical Transparency in 2025September 17th 2025
IQVIA and Veeva Join Forces to Improve Efficiency and Patient OutcomesSeptember 17th 2025
Managing Background Therapies in the NIMBLE Phase III TrialSeptember 17th 2025
Generative AI Transforms Clinical Study Report DevelopmentSeptember 16th 2025
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
